tegafur has been researched along with Carcinoid Tumor in 5 studies
Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 5.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 1.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| " Dose escalation was required in order to control carcinoid symptoms, and the final dosage was 5,950 micrograms/day." | 1.29 | Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide. ( Deguchi, H; Deguchi, K; Iwasaki, E; Kobayashi, T; Murashima, S; Shirakawa, S; Tsuda, M; Tsukada, T, 1994) |
| "UFT was given to two patients with carcinoid tumor of the stomach and the effect of the drug was evaluated." | 1.26 | [Two cases of carcinoid tumor of the stomach which responded to oral administration of UFT]. ( Hirota, T; Okazaki, N; Tajiri, H; Yamaguchi, H; Yoshida, S; Yoshimori, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, S | 1 |
| Kimura, S | 1 |
| Kashima, M | 1 |
| Shichijo, K | 1 |
| Yoshida, S | 2 |
| Harada, E | 1 |
| Matsushita, T | 1 |
| Oshima, Y | 1 |
| Tamaki, Y | 1 |
| Horiuchi, N | 1 |
| Takeichi, T | 1 |
| Fujimoto, H | 1 |
| Masuda, K | 1 |
| Iwasaka, N | 1 |
| Shinomiya, S | 1 |
| Borchard, F | 1 |
| Yoshimori, M | 1 |
| Okazaki, N | 1 |
| Tajiri, H | 1 |
| Yamaguchi, H | 1 |
| Hirota, T | 1 |
| Deguchi, H | 1 |
| Deguchi, K | 1 |
| Tsukada, T | 1 |
| Murashima, S | 1 |
| Iwasaki, E | 1 |
| Tsuda, M | 1 |
| Kobayashi, T | 1 |
| Shirakawa, S | 1 |
| Prior, MJ | 1 |
| Maxwell, RJ | 1 |
| Griffiths, JR | 1 |
1 review available for tegafur and Carcinoid Tumor
| Article | Year |
|---|---|
[The diffuse endocrine system and the carcinoids of the alimentary tract. Part I: Orthological aspects and common morphological features of the carcinoids (author's transl)].
Topics: Adrenocorticotropic Hormone; Aged; Appendiceal Neoplasms; APUD Cells; Carcinoid Tumor; Carmustine; C | 1982 |
4 other studies available for tegafur and Carcinoid Tumor
| Article | Year |
|---|---|
[A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Colonic Neoplasms; Colonoscop | 2008 |
[Two cases of carcinoid tumor of the stomach which responded to oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; C | 1982 |
Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Combined Modal | 1994 |
In vivo 19F NMR spectroscopy of the antimetabolite 5-fluorouracil and its analogues. An assessment of drug metabolism.
Topics: Animals; Antineoplastic Agents; beta-Alanine; Carcinoid Tumor; Female; Floxuridine; Fluorouracil; In | 1990 |